Adjuvax LLC
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.0Mattributed |
|---|---|
| Latest round | grant, $3.0M, 2025-01-01attributed |
| Founded | 2018 |
| Headquarters | Hoover, Alabama |
| Industry | bio |
| Stage | unknown |
| Website | adjuvax.net |
Adjuvax develops saponin-based vaccine adjuvants designed to strengthen immune responses to vaccines. It serves vaccine manufacturers and developers, including those targeting immunocompromised populations. Its differentiator is potent, cost-effective, structurally defined adjuvants with diverse activity profiles from new formulations.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | grant | $3.0M | undisclosed |
Detected tech stack
Cloudflare, WordPress 7.0, LiteSpeed, LiteSpeed Cache, Parsley.js, PHP, WordPress Block Editor, MySQL, jquery 3.7.1, bootstrap 5.0.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | adjuvax.net, read 2026-05-02 |
| Description | self-reported | adjuvax.net, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.